Premium
Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
Author(s) -
Vasanthakumar Natesan
Publication year - 2020
Publication title -
bioessays
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.175
H-Index - 184
eISSN - 1521-1878
pISSN - 0265-9247
DOI - 10.1002/bies.202000094
Subject(s) - medicine , ards , adrenergic , covid-19 , clinical trial , pathophysiology , intensive care medicine , disease , receptor , lung , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom